JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB43125

Anti-beta Dystroglycan antibody

3

(3 Reviews)

|

(6 Publications)

Rabbit Polyclonal DAG1 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.

View Alternative Names

Dystroglycan 1, Dystroglycan, Dystrophin-associated glycoprotein 1

4 Images
Western blot - Anti-beta Dystroglycan antibody (AB43125)
  • WB

Unknown

Western blot - Anti-beta Dystroglycan antibody (AB43125)

Lanes 1-3 : Merged signal (red and green). Green - ab43125 observed at 43 kDa. Red - loading control, ab8245 observed at 37 kDa.

ab43125 Anti-beta Dystroglycan antibody was shown to specifically react with beta Dystroglycan in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266263 (knockout cell lysate ab257192) was used. Wild-type and beta Dystroglycan knockout samples were subjected to SDS-PAGE. ab43125 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1/500 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

DAG1 knockout HEK293T cell lysate at 20 µg

Lane 3:

Human skeletal muscle tissue lysate at 20 µg

Predicted band size: 97 kDa

Observed band size: 43 kDa

false

Western blot - Anti-beta Dystroglycan antibody (AB43125)
  • WB

Lab

Western blot - Anti-beta Dystroglycan antibody (AB43125)

Lanes 1-3 : Merged signal (red and green). Green - ab43125 observed at 43 kDa. Red - loading control, ab8245 observed at 37 kDa.

ab43125 Anti-beta Dystroglycan antibody was shown to specifically react with beta Dystroglycan in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266263 (knockout cell lysate ab257192) was used. Wild-type and beta Dystroglycan knockout samples were subjected to SDS-PAGE. ab43125 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1/500 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human DAG1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-dag1-knockout-hek-293t-cell-line-ab266263'>ab266263</a>)

Lane 2:

DAG1 knockout HEK293T cell lysate at 20 µg

Lane 3:

Human skeletal muscle tissue lysate at 20 µg

Predicted band size: 97 kDa

Observed band size: 43 kDa

false

Western blot - Anti-beta Dystroglycan antibody (AB43125)
  • WB

Lab

Western blot - Anti-beta Dystroglycan antibody (AB43125)

ab43125 was shown to react with DAG1 in wild-type A431 cells in Western blot with loss of signal observed in a DAG1 knockout cell line. Wild-type A431 and DAG1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab43125 overnight at 4 °C at a 1/500 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1/500 dilution

Lane 1:

Wild-type A431 lysate at 90 µg

Lane 2:

DAG1 knock-out A431 lysate at 90 µg

false

Western blot - Anti-beta Dystroglycan antibody (AB43125)
  • WB

Project

Western blot - Anti-beta Dystroglycan antibody (AB43125)

All lanes:

Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1 µg/mL

Lane 1:

Human brain tissue lysate - total protein (<a href='/en-us/products/unavailable/human-brain-tissue-lysate-total-protein-ab29466'>ab29466</a>) at 10 µg

Lane 2:

Human heart tissue lysate - total protein (<a href='/en-us/products/unavailable/human-heart-tissue-lysate-total-protein-ab29431'>ab29431</a>) at 10 µg

Lane 3:

Human skeletal muscle tissue lysate - total protein (<a href='/en-us/products/unavailable/human-skeletal-muscle-tissue-lysate-total-protein-ab29330'>ab29330</a>) at 10 µg

Secondary

All lanes:

IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

Predicted band size: 97 kDa

Observed band size: 43 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rabbit": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta Dystroglycan also known as β-DG is a transmembrane protein with a molecular mass of approximately 43 kDa. It plays a mechanical role by linking the extracellular matrix to the cytoskeleton acting as a part of the dystrophin-glycoprotein complex. This protein is widely expressed in many tissues including skeletal muscle cardiac muscle and the central nervous system. Beta Dystroglycan serves as a receptor for components like laminin and agrin in the extracellular matrix.
Biological function summary

Beta Dystroglycan acts as a structural and signaling molecule within the dystrophin-glycoprotein complex. This complex stabilizes the sarcolemma during muscle contraction and helps in protecting muscle fibers from injury. Beta Dystroglycan also contributes to cellular signaling pathways by interacting with various intracellular proteins like dystrophin and alpha dystroglycan. It regulates cell adhesion and migration processes critical for tissue maintenance and repair.

Pathways

Beta Dystroglycan plays a critical role in the integrity of the dystrophin-associated glycoprotein complex. It is involved in the AKT signaling pathway which is essential for cellular growth and survival. Moreover beta Dystroglycan interacts closely with proteins such as dystrophin and utrophin facilitating their functions in muscle cells. Its interactions help maintain cell membrane stability and signal transduction processes important for normal cellular functions.

Beta Dystroglycan’s dysfunction has been closely linked to muscular dystrophies specifically Duchenne and Becker muscular dystrophies. These conditions involve muscle weakness and degeneration linked to abnormalities in the dystrophin-glycoprotein complex. Additionally aberrant glycosylation and signaling of beta Dystroglycan contribute to cancer progression through altered cell adhesion and migration often involving interactions with proteins like α-dystroglycan.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization.. Alpha-dystroglycan. Extracellular peripheral glycoprotein that acts as a receptor for extracellular matrix proteins containing laminin-G domains. Receptor for laminin-2 (LAMA2) and agrin in peripheral nerve Schwann cells. Also acts as a receptor for laminin LAMA5 (By similarity).. Beta-dystroglycan. Transmembrane protein that plays important roles in connecting the extracellular matrix to the cytoskeleton. Acts as a cell adhesion receptor in both muscle and non-muscle tissues. Receptor for both DMD and UTRN and, through these interactions, scaffolds axin to the cytoskeleton. Also functions in cell adhesion-mediated signaling and implicated in cell polarity.. Alpha-dystroglycan. (Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus glycoprotein and class C new-world arenaviruses (PubMed : 16254364, PubMed : 17360738, PubMed : 19324387). Acts as a Schwann cell receptor for Mycobacterium leprae, the causative organism of leprosy, but only in the presence of the G-domain of LAMA2 (PubMed : 9851927).
See full target information Dystroglycan

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 12:3186 PubMed35210456

2022

Sex-specific differences in KCC2 localisation and inhibitory synaptic transmission in the rat hippocampus.

Applications

Unspecified application

Species

Unspecified reactive species

Daniele C Wolf,Nathalie T Sanon,Alexandra O S Cunha,Jia-Shu Chen,Tarek Shaker,Abdul-Rahman Elhassan,Antônia Sâmia Fernandes do Nascimento,Graziella Di Cristo,Alexander G Weil

The Journal of physiology 597:4831-4850 PubMed31340406

2019

Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.

Applications

Unspecified application

Species

Unspecified reactive species

S Trajanovska,J Ban,J Huang,P Gregorevic,M Morsch,D G Allen,W D Phillips

HRB open research 1:17 PubMed35528858

2018

Chemical crosslinking analysis of β-dystroglycan in dystrophin-deficient skeletal muscle.

Applications

Unspecified application

Species

Unspecified reactive species

Sandra Murphy,Margit Zweyer,Rustam R Mundegar,Dieter Swandulla,Kay Ohlendieck

Cerebral cortex (New York, N.Y. : 1991) 28:4049-4062 PubMed30169756

2018

KCC2 Regulates Dendritic Spine Formation in a Brain-Region Specific and BDNF Dependent Manner.

Applications

Unspecified application

Species

Unspecified reactive species

Patricia Nora Awad,Clara Akofa Amegandjin,Joanna Szczurkowska,Josianne Nuñes Carriço,Antônia Samia Fernandes do Nascimento,Elie Baho,Bidisha Chattopadhyaya,Laura Cancedda,Lionel Carmant,Graziella Di Cristo

Journal of proteomics 191:212-227 PubMed29408692

2018

Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.

Applications

Unspecified application

Species

Unspecified reactive species

Sandra Murphy,Margit Zweyer,Michael Henry,Paula Meleady,Rustam R Mundegar,Dieter Swandulla,Kay Ohlendieck

BMC research notes 10:601 PubMed29157305

2017

Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene.

Applications

Unspecified application

Species

Unspecified reactive species

Francesca Sciandra,Bianca Maria Scicchitano,Giulia Signorino,Maria Giulia Bigotti,Barbara Tavazzi,Francesca Lombardi,Manuela Bozzi,Gigliola Sica,Bruno Giardina,Sandra Blaess,Andrea Brancaccio
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com